Recent News

• 02.10.2026 - Volition Announces the Appointment of New Distributor for Nu.Q® Discover
• 02.09.2026 - VolitionRx Receives Notice of Non-Compliance with NYSE American Continued Listing Standards
• 02.04.2026 - Volition Sponsors Symposium at 15th Conference of the European Hidradenitis Suppurativa Foundation
• 01.30.2026 - VolitionRx Limited Announces the Preparation of Reimbursement Submission for its Nu.Q® Cancer Assays
• 01.27.2026 - Volition Announces Data to Support Use of Nu.Q® NETs in New Indication

Recent Filings

• 02.09.2026 - S-3 Registration statement under Securities Act of 1933
• 02.09.2026 - EX-99.1 EX-99.1
• 02.09.2026 - 8-K Current report
• 02.03.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.03.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.03.2026 - 4 Statement of changes in beneficial ownership of securities
• 01.28.2026 - D/A Notice of Exempt Offering of Securities
• 01.26.2026 - PRE 14A Other preliminary proxy statements
• 01.23.2026 - 4 Statement of changes in beneficial ownership of securities
• 01.23.2026 - 4 Statement of changes in beneficial ownership of securities